CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 4 Open-market buy Chief Financial Officer bought 2,125 shares at $7.05 ($14,981)
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 4 Open-market sale Chief Operating Officer sold 4,000 shares at $7.50 ($30,000)
- 4 Option exercise President and CEO acquired 3,467 shares (option exercise)
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale Director sold 6,774 shares at $6.22 ($42,122)
- 4 Open-market sale Director sold 10,000 shares at $6.39 ($63,913)
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 POS Other Post-effective Amendment
- 4 Open-market sale Director sold 10,000 shares at $6.26 ($62,591)
- 4 Open-market sale Director sold 10,000 shares at $6.44 ($64,361)
- 4 Open-market sale Director sold 10,000 shares at $6.64 ($66,373)
Page 29 of 49 · 978 filings